Comparative efficacy of single-inhaler triple therapies for COPD: A protocol for systematic review and network meta-analysis.
<h4>Introduction</h4>2021 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Reports recommends that patients with clinically significant symptoms and exacerbations of chronic obstructive pulmonary disease (COPD) should escalate to triple therapy, a combined use of inhaled cor...
Guardado en:
Autores principales: | Yixuan Jiang, Hao Hu, Siu-Wai Leung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/877c6ad7b0984407a30aea2b3ed51881 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
por: Sandeep Bansal, et al.
Publicado: (2021) -
Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review
por: Sven L. Klijn, et al.
Publicado: (2017) -
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
por: Mònica Monteagudo, et al.
Publicado: (2021) -
Device errors in asthma and COPD: systematic literature review and meta-analysis
por: Henry Chrystyn, et al.
Publicado: (2017) -
Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study.
por: Patrick White, et al.
Publicado: (2013)